Related Experiment Videos
Serotonin regulation of aldosterone secretion
E Maestri1, L Camellini, G Rossi
1University of Parma, Italy.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|July 1, 1988
Summary
This study reveals that serotonin influences aldosterone secretion in healthy individuals. Serotonergic activation increased aldosterone, suggesting a physiological control mechanism.
Area of Science:
- Endocrinology
- Neuroendocrinology
- Pharmacology
Background:
- Aldosterone (A) and cortisol (F) are key hormones regulated by the hypothalamic-pituitary-adrenal axis.
- Serotonin (5-hydroxytryptophan, 5OHT) is a neurotransmitter with known effects on various physiological systems.
- The precise role of serotonergic pathways in regulating aldosterone secretion remains incompletely understood.
Purpose of the Study:
- To investigate the effect of acute oral administration of 5-hydroxytryptophan (5OHT) and pizotifen (Piz) on circulating levels of aldosterone, cortisol, ACTH, prolactin, potassium, and plasma renin activity (PRA) in healthy subjects.
- To explore the potential involvement of central serotonergic pathways in the control of aldosterone secretion.
- To examine the influence of dexamethasone pretreatment on the hormonal responses to 5OHT.
Main Methods:
- Eight healthy normotensive subjects (6 males, 2 females) participated in the study.
- Subjects received oral administration of 5-hydroxytryptophan (5OHT), pizotifen (Piz), or placebo.
- 5-hydroxytryptophan was administered twice: once after placebo and once after dexamethasone pretreatment.
- Circulating levels of aldosterone, cortisol, ACTH, prolactin, potassium, and plasma renin activity (PRA) were measured.
Main Results:
- 5-hydroxytryptophan administration, combined with placebo, significantly increased aldosterone, ACTH, and cortisol levels, without altering PRA, potassium, or prolactin.
- Dexamethasone pretreatment suppressed ACTH and cortisol but did not affect the aldosterone response to 5-hydroxytryptophan.
- Pizotifen administration resulted in a significant decrease in aldosterone levels only, with no significant changes in other measured parameters.
- Placebo administration led to a slight, non-significant decrease in the studied parameters.
Conclusions:
- The findings suggest a physiological role for serotonergic pathways in controlling aldosterone secretion.
- A pituitary factor may mediate the link between central serotonergic activation and adrenal aldosterone release.
- Serotonergic modulation of the adrenal axis warrants further investigation, particularly concerning the specific mechanisms involved.